Concentrix (CNXC) Competitors

Concentrix (NASDAQ:CNXC) and UL Solutions (NYSE:ULS) are both business services companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Does the MarketBeat Community favor CNXC or ULS?

Concentrix received 6 more outperform votes than UL Solutions when rated by MarketBeat users. However, 58.82% of users gave UL Solutions an outperform vote while only 55.32% of users gave Concentrix an outperform vote.

Company	Underperform	Outperform
Concentrix	Outperform Votes 26 55.32%	Underperform Votes 21 44.68%
UL Solutions	Outperform Votes 20 58.82%	Underperform Votes 14 41.18%

Is CNXC or ULS a better dividend stock?

Concentrix pays an annual dividend of $1.33 per share and has a dividend yield of 2.4%. UL Solutions pays an annual dividend of $0.52 per share and has a dividend yield of 0.7%. Concentrix pays out 33.3% of its earnings in the form of a dividend. UL Solutions pays out 31.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Concentrix has raised its dividend for 3 consecutive years. Concentrix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Do insiders and institutionals believe in CNXC or ULS?

90.3% of Concentrix shares are owned by institutional investors. 3.2% of Concentrix shares are owned by company insiders. Comparatively, 1.2% of UL Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Is CNXC or ULS more profitable?

UL Solutions has a net margin of 11.36% compared to Concentrix's net margin of 2.61%. UL Solutions' return on equity of 44.52% beat Concentrix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Concentrix	2.61%	16.67%	5.63%
UL Solutions	11.36%	44.52%	12.48%

Do analysts recommend CNXC or ULS?

Concentrix currently has a consensus price target of $65.75, suggesting a potential upside of 18.28%. UL Solutions has a consensus price target of $69.43, suggesting a potential downside of 3.01%. Given Concentrix's stronger consensus rating and higher probable upside, research analysts clearly believe Concentrix is more favorable than UL Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concentrix	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00
UL Solutions	0 Sell rating(s)	5 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.38

Does the media prefer CNXC or ULS?

In the previous week, UL Solutions had 7 more articles in the media than Concentrix. MarketBeat recorded 17 mentions for UL Solutions and 10 mentions for Concentrix. UL Solutions' average media sentiment score of 1.33 beat Concentrix's score of 1.06 indicating that UL Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Concentrix	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
UL Solutions	11 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings and valuation, CNXC or ULS?

UL Solutions has lower revenue, but higher earnings than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than UL Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concentrix	$9.59B	0.37	$251.22M	$3.99	13.93
UL Solutions	$2.91B	4.93	$260M	$1.67	42.86

Summary

Concentrix and UL Solutions tied by winning 10 of the 20 factors compared between the two stocks.